Madrigal Pharmaceuticals, Inc. (MDGL) NASDAQ

290.72

-0.24(-0.08%)

Updated at May 19 04:00PM

Currency In USD

Valuation

Market Cap6.56B
Enterprise Value6.58B
P/E Ratio-16.4
PEG Ratio-0.88
Price/Sales Ratio20.34
Price/Book Ratio9.04
Enterprise/Revenue20.14
Enterprise/EBITDA-16.99

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-1.23
Operating Margin-1.34

Management Effectiveness

Return On Assets-0.39
Return On Equity-0.51

Income Statement

Revenue180.13M
Revenue/Share14.37
Gross Profit173.9M
EBITDA-450.13M
Net Income-465.89M
Diluted EPS-21.9

Balance Sheet

Total Cash843.07M
Total Cash/Share38.16
Total Debt119.77M
Total Debt/Equity0.17
Current Ratio5.91
Book Value Per Share32.17

Price History

52-Week Change25.26
52-Week High377.46
52-Week Low200.63
Moving Average 50 Days319.53
Moving Average 200 Days292.24

Statistics

Average Volume372,201
Shares Outstanding22.2M
% Held by Institutions105.61

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:35
Last Split DateJuly 25, 2016